Colorectal Cancer

The gap in cancer mortality between Black and white individuals shrunk dramatically during the past 3 decades, according to a new report.

Moderate to vigorous aerobic and resistance exercise may improve vascular function among cancer survivors, according to findings presented at American Association for Cancer Research Annual Meeting.

Federally qualified health centers reported substantially lower breast, cervical and colorectal cancer screenings compared with the general U.S. population, highlighting a gap in screening rates for adults from underrepresented groups.

Colorectal cancer incidence climbed 500% from 1999 to 2020 among children aged 10 to 14 years and 333% among adolescents aged 15 to 19 years, according to research presented at the Digestive Disease Week media briefing.

Screenings for breast, cervical and colorectal cancers were significantly lower in federally qualified health centers compared with the general population, a study in JAMA Internal Medicine showed.

New testing options for colorectal cancer will likely expand access to screening, but they are not as reliable as a colonoscopy, according to experts.

The FDA has approved Geneoscopy Inc.’s ColoSense multitarget stool RNA test for adults aged 45 years or older at average-risk for developing colorectal cancer, according to a company press release.

The 10-year interval between screening colonoscopies “could potentially be extended” to 15 years among patients without a family history of colorectal cancer and negative findings for CRC at the first colonoscopy, researchers reported.

Native Hawaiian and other Pacific Islander individuals in the United States are two to three times more likely to die of certain cancers than white individuals, according to an American Cancer Society report.

Whereas previous studies have shown aspirin use decreases incidence and mortality of colorectal cancer, researchers may now have insight into why this occurs, according to study results published in Cancer.